Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Salt Formation and Purification. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102174049A details a refined salting process eliminating column chromatography, ensuring high purity and cost reduction in pharmaceutical intermediates manufacturing.
Advanced purification method for Lesinurad intermediate achieving over 99% HPLC purity. Cost-effective salt formation technology for reliable pharmaceutical supply chains.
Advanced purification method for Ilaprazole Sodium ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN112694445A reveals a high-purity purification method for Elagolix intermediates using L-tartaric acid, ensuring >99% purity for scalable API manufacturing.
Patent CN113979877A details a novel salt-formation refining method for Efavirenz intermediates, offering superior purity and waste recovery for pharmaceutical supply chains.
Advanced patent CN121064183A enables high-purity isaconazole sulfate intermediate production with reduced impurities and optimized supply chain reliability for global pharmaceutical manufacturing.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Discover the patented purification method for Chlorin e6 achieving >99% purity. A scalable, cost-effective solution for photodynamic therapy intermediates.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.